UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020651
Receipt number R000023827
Scientific Title Effectiveness of honey and expectorant for nocturnal cough in children with acute upper respiratory infection : a prospective interventional study
Date of disclosure of the study information 2016/01/25
Last modified on 2024/02/05 12:06:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of honey and expectorant for nocturnal cough in children with acute upper respiratory infection : a prospective interventional study

Acronym

Effectiveness of honey for nocturnal cough in children: a prospective interventional study

Scientific Title

Effectiveness of honey and expectorant for nocturnal cough in children with acute upper respiratory infection : a prospective interventional study

Scientific Title:Acronym

Effectiveness of honey for nocturnal cough in children: a prospective interventional study

Region

Japan


Condition

Condition

acute upper respiratory infection in children

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We verify the effectiveness of honey for nocturnal cough in children with acute upper respiratory infection compared to expectorant.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in frequency of nocturnal cough on the next day when honey or expectorant had been given prior to bedtime compared to that on the first day of presentation when no medication had been given.

Key secondary outcomes

Change in severity of nocturnal cough, bothersome cough, appetite and quality of sleep at night on the next day when honey or expectorant had been given prior to bedtime compared to that on the first day of presentation when no medication had been given.
Improvement of nocturnal cough one week after when honey or expectorant had been given prior to bedtime compared to that on the first day of presentation when no medication had been given.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Honey Group:
Patients in this group take honey (5g for 2-5y, 10g for 6y-) prior to bedtime orally for a week.

Interventions/Control_2

Expectorant Group:
Patients in this group take expectorants (eg. Carbocisteine 30mg/kg/day and Ambroxol 0.9mg/kg/day) orally for a weak.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

2 years-old <=

Age-upper limit

16 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patient diagnosed with acute upper respiratory infection with cough for 7 or fewer days duration.
2) nocturnal cough score 3 or more (using a 7point Likert scale)

Key exclusion criteria

1) Following medications had been given for patient on the day before or after
:Antihistamines, beta2agonists, Steroids, Leukotriene receptor antagonists
eg) asthma, atopic dermatitis, allergic rhinitis
2) Patient admitted to hospital
3) Patient with underlying disease
eg) Cerebral palsy, Congenital heart disease, Chronic lung disease, Myopathy, Malformation syndrome, Immunodeficiency

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Kazushi
Middle name
Last name Agata

Organization

Tokyo Medical University Hachioji Medical Center

Division name

Pediatrics

Zip code

1930998

Address

1163 Tatemachi, Hachioji, Tokyo, Japan

TEL

0426655611

Email

tokyoseki2016@gmail.com


Public contact

Name of contact person

1st name Shun
Middle name
Last name Kishibe

Organization

Tokyo Metropolitan Children's Medical Center

Division name

Pediatric Emergency Medicine

Zip code

19309988

Address

2-8-29 Musashidai, Fuchu-shi, Tokyo, Japan

TEL

042-300-5111

Homepage URL


Email

jemstone625@gmail.com


Sponsor or person

Institute

Tokyo Medical University Hachioji Medical Center

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical University Hachioji Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hashimoto pediatric Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Metropolitan Children's Medical Center

Address

2-8-29 Musashidai, Fuchu-shi, Tokyo, Japan

Tel

0423005111

Email

shun_kishibe@tmhp.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科大学八王子医療センター


Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 01 Month 13 Day

Date of IRB

2016 Year 01 Month 13 Day

Anticipated trial start date

2016 Year 01 Month 25 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry

2017 Year 09 Month 30 Day

Date trial data considered complete

2018 Year 02 Month 26 Day

Date analysis concluded

2024 Year 03 Month 30 Day


Other

Other related information



Management information

Registered date

2016 Year 01 Month 20 Day

Last modified on

2024 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023827


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name